Home DPN Check®

DPN Check® — The Science Behind Our Nerve Testing

An FDA-cleared, point-of-care nerve conduction device backed by 35+ peer-reviewed studies — detecting hidden nerve damage in seconds.

FDA-Cleared · NC-stat® 35+ Peer-Reviewed Studies
DPN Check device in use
Diabetes CareThe Lancet Diabetes & Endocrinology J. of Diabetes InvestigationPLOS ONE
The Science

Objective measurement, not guesswork

DPN Check® (NC-stat®) is an FDA-cleared point-of-care nerve conduction device backed by 35+ peer-reviewed studies published in leading journals — Diabetes Care, The Lancet Diabetes & Endocrinology, the Journal of Diabetes Investigation, and PLOS ONE.

Research shows DPN Check® not only identifies early nerve damage but can help predict the risk of kidney function decline, diabetic retinopathy progression, and overall health outcomes — risks that HbA1c alone may not detect.

The Advantages

Why DPN Check®?

Advanced, non-invasive nerve conduction testing trusted by clinicians worldwide — delivering objective results in seconds.

FDA Cleared Technology

FDA-Cleared Technology

FDA-cleared nerve conduction testing technology — a regulated, objective standard for detecting peripheral nerve damage.

~90% Sensitivity vs EMG

Approximately 90% sensitivity compared to traditional electromyography (EMG) — without the discomfort of needle testing.

Non-Invasive & Painless

Non-Invasive & Painless

A completely non-invasive and painless procedure — no needles, no discomfort, and no recovery time required.

Results in 10–15 Seconds

Objective results are available within 10–15 seconds — enabling immediate discussion and decision-making at the point of care.

2 Million+ Assessments Worldwide

Trusted in over 2 million patient assessments worldwide — a proven track record across clinics and research settings globally.

The Evidence

Proven Performance, Measured Results

The numbers behind why DPN Check® has become a benchmark for early nerve damage detection.

90%

Approximately 90% sensitivity vs EMG — matching traditional electromyography without the needles.

15s

Objective results in as little as 15 seconds to a result, right at the point of care.

2M+

Trusted in over 2 million+ assessments worldwide across clinics and research studies.

The Advantage

Early detection of hidden nerve damage enables timely intervention, helping prevent serious diabetes-related complications before symptoms appear.

Act Early

See what a sugar test can't

Book your FDA-cleared nerve assessment today.

Chat on WhatsApp